Home / Inspections / 1295872

FDA Inspection 1295872 — Michal Krawczynski, MD

Michal Krawczynski, MD — FEI 3040508899

The FDA completed an inspection of Michal Krawczynski, MD on Nov 21, 2025 in Poznan. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 21, 2025
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Poznan (Poland)

Additional Details

Clinical Investigator (CI)

Facility

FDA data resources

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.